The Cancer Research Institute 2017 Immunotherapy Patient Summit Series will travel to five U.S. cities to provide free educational programming designed for cancer patients and caregivers who are seeking to learn more about cancer immunotherapy and clinical trials.
Cancer Research Institute to bring together cancer patients, leading immunotherapy manufacturers, and Highland Falls community members for Second Annual Answer to Cancer Cycling and 5K Run/Walk Event Sponsored by Bristol-Myers Squibb on Saturday, June 10, 2017
30 days of educational and awareness programming and special events for patients, caregivers, and the public about cancer immunotherapy, clinical trials, and the need to fund more research
Data from four CRI-funded early-phase immunotherapy combination trials will be presented at the American Society for Clinical Oncology (ASCO) Annual meeting in Chicago in June.
Nonprofit Cancer Research Institute appoints pharmaceutical executive to lead its clinical research program
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Immunotherapy tripled the median progression-free survival rate among lung cancer patients compared to those who received only chemotherapy and radiation
We introduce you to Thomas Hudson, M.D., vice president, head of oncology discovery and early development at AbbVie.